Register for April 25, 2017 Webinar


Tuesday, April 25, 2017, 2:00 PM - 3:00 PM EDT 

Program Description 

A Managed Care Evaluation of the Dyslipidemia Management Advances 

Over 73 million adults in the United States have dyslipidemia and are at elevated risk for atherosclerotic cardiovascular disease. In 2015, the approval of two proprotien convertase subtilisin/kexin type 9 (PCSK9) inhibitors provided new options to dramatically improve lipid profiles. However, the PCSK9 inhibitors have created unprecedented challenges for health care payers due to the specialty nature of the medications, the large potential volume of patients, and the lack of definitive guidance on the use of nonstatin therapies in the treatment of dyslipidemia. Evidence-based strategies to identify the most appropriate patients for treatment with PCSK9 inhibitors are needed to support rational use of limited healthcare resources while optimizing patient care.

This program will delve into the role of nonstatin therapies in dyslipidemia management, review outcomes related to formulary and utilization management techniques, and explore the potential impact of newer agents on patient care.

Learning Objectives 

At the completion of this activity, participants should be able to:

  1. Summarize current guidelines for the treatment of dyslipidemia, including the 2016 ACC Expert Consensus Decision Pathway on the role of nonstatin therapies.
  2. Use current evidence to identify patient populations that are expected to derive the greatest benefit from nonstatin therapies.
  3. Describe “statin intolerance” and “statin failure” and appropriate treatment options for patients with either of these conditions.
  4. Use current data to describe the impact of newer therapies on patient care.

Target Audience 

This knowledge-based activity has been designed to meet the educational needs of pharmacists in managed care settings.

Faculty Presenters 

Seth S. Martin, MD, MHS, FACC
Assistant Professor of Medicine and Cardiology
Firm Faculty, Janeway Firm, Osler Medical Residency
Co-Director, Hopkins Lipid Clinic, Ciccarone Center for the Prevention of Heart Disease
Associate Faculty, Welch Center for Prevention, Epidemiology, and Clinical Research
The Johns Hopkins University Medical Institutions
Baltimore, Maryland

Greg Low, RPh, PhD
Program Director, MGPO Pharmacy Quality & Utilization Program
Performance Analysis & Improvement
Massachusetts General Hospital
Boston, Massachusetts



Christine L. Cooper, PharmD
Education Program Manager
Academy of Managed Care Pharmacy
Alexandria, Virginia

2:00 pm to 2:05 pm        Welcome and Introductions
Christine L. Cooper, PharmD 
2:05 pm to 2:30 pm   Advances in Treating Dyslipidemia: The Clinical Perspective
Seth Martin, MD, MHS, FACC 
2:30 pm to 2:50 pm   Advances in Treating Dyslipidemia: The Managed Care Perspective
Greg Low, RPh, PhD 
2:50 pm to 3:00 pm   Audience Q&A
Christine L. Cooper, PharmD

ACPE UAN #: 0233-0000-17-039-L01-P

Credit: 1.0 contact hours (0.1 CEU)

Activity Type: Knowledge-based

Activity Fee: There is no fee to participate in this activity.

 ACPE LogoThe Academy of Managed Care Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

As an ACPE-accredited provider, AMCP strictly adheres to the ACPE Standards for Commercial Support and other relevant guidelines and standards to ensure the independence of CPE activities. It is AMCP’s intent that all CPE activities be independent, objective, balanced, evidence-based and free of any commercial bias.

 AMCP Logo 

Earning CPE Credit 

To earn CPE, participation in the pre- and post-test questions is required. Once completed, go to to claim continuing pharmacy education (CPE) credit for this program. In the enrollment code redemption area, enter the enrollment code provided during the session. Complete the program evaluation and enter your NABP ID, birth month and birth day. All CPE credit for this webinar activity must be completed no later than 5:00 PM EDT on Friday, May 26, 2017. No exceptions will be made after this date.

Statement of Commercial Support 

This educational activity is supported by an unrestricted education grant from Amgen. 


This continuing education activity is provided at no cost to participants, but space is limited to the first 500 participants that join the webinar.

System Technical Requirements/Viewing Requirements  

For all activities you should have a basic comfort level using a computer and navigating web sites.

The live webinar is delivered through GoToWebinar. To view minimum technical and system requirements for the webinar, please use your web browser to check your system requirements by clicking here.

The handout will be delivered via Acrobat PDF.

CPE credit will be claimed through AMCP Learn. View the minimum technical and system requirements for continuing education online learning activities by clicking here.